CVE-2025-33120

IBM QRadar SIEM privilege escalation

Description

IBM QRadar SIEM 7.5 through 7.5.0 UP13 could allow an authenticated user to escalate their privileges via a misconfigured cronjob due to execution with unnecessary privileges.

Remediation

Solution:

  • IBM encourages customers to update their systems promptly. ProductVersionFixIBM QRadar SIEM 7.5.0 QRadar 7.5.0 UP13 IF01 https://www.ibm.com/support/fixcentral/swg/selectFixes QRadar Incident Forensics 7.5.0 QIF 7.5.0 UP13 IF01 https://www.ibm.com/support/fixcentral/swg/selectFixes

Category

7.8
CVSS
Severity: High
CVSS 3.1 •
EPSS 0.01%
Vendor Advisory ibm.com
Affected: IBM QRadar SIEM
Published at:
Updated at:

References

Link Tags
https://www.ibm.com/support/pages/node/7242869 patch vendor advisory

Frequently Asked Questions

What is the severity of CVE-2025-33120?
CVE-2025-33120 has been scored as a high severity vulnerability.
How to fix CVE-2025-33120?
To fix CVE-2025-33120: IBM encourages customers to update their systems promptly. ProductVersionFixIBM QRadar SIEM 7.5.0 QRadar 7.5.0 UP13 IF01 https://www.ibm.com/support/fixcentral/swg/selectFixes QRadar Incident Forensics 7.5.0 QIF 7.5.0 UP13 IF01 https://www.ibm.com/support/fixcentral/swg/selectFixes
Is CVE-2025-33120 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2025-33120 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2025-33120?
CVE-2025-33120 affects IBM QRadar SIEM.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.